(firstQuint)CC-223 and Ketoconazole Drug-Drug Interaction Study.

 This is a 2 period study, which lasts about 6 weeks long.

 About 14 males will be entered into the study, during which they will receive the study drug (a single dose of 20 mg CC-223) 400 mg ketoconazole.

.

 CC-223 and Ketoconazole Drug-Drug Interaction Study@highlight

This is a single-center open-label study to compare how CC-223 (the study drug being investigated) interacts with the drug ketoconazole.

